| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Huh Yong-Jun serves as a Director at ARTV. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $11.5M at current prices.
The biggest single holding is ARTV (~$11.5M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 2,083,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | ARTV Artiva Biotherapeutics, Inc. | Director | Buy | 2,083,332 | $12.00 | $24,999,984.00 | +83.9% | -11.0% | -78.1% |